上海新黄河制药

Shanghai New Huanghe Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer based in Shanghai, China, and operates as a key subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH). The company focuses on the production of high-quality chemical generic drugs, particularly in the fields of metabolic disorders, cardiovascular diseases, and nutritional health. Its core product line includes essential medications such as metformin hydrochloride and gliclazide for diabetes management, as well as a comprehensive range of vitamin supplements. With a history rooted in the merger of established local pharmaceutical assets, the company maintains advanced manufacturing facilities that comply with national GMP standards. Shanghai New Huanghe Pharmaceutical plays a vital role in SPH's supply chain, ensuring the availability of affordable chronic disease treatments for the Chinese healthcare system. The company continues to optimize its production processes and expand its portfolio of oral solid dosage forms.